LC/MS/MS Solutions for Targeted and Non-Targeted Small Molecule and Protein Biomarker Discovery, Verification and Validation Henri Snijders, European Marketing Manager Small Molecules, Applied Biosystems speaking at the European Biomarkers Summit 2006.
Novel Approach to Active Metabolite Identification Allowing Early Access to Metabolic Profiling Studies to Improve Lead Candidate Selection Dr. Danny van Elswijk, Screening Director, Kiadis BV, speaking at Advances in Metabolic Profiling 2005.
Identification of Major Metabolism Regulators from Metabolic Profiles Dr. Anton Yuryev, Executive Director of Application Science, Ariadne Genomics Inc., speaking at Advances in Metabolic Profiling 2005.
Metabolomics in the Drug Discovery Process: Interactions With Other -omes Dr Julian L. Griffin, University of Cambridge speaking at Advances in Metabolomic Profiling 2005.
Predicting Clinical Resistance to Gleevec Treatment by in vitro Applied Stable Isotope-based Dynamic Metabolic Profiling Laszlo G. Boros, Los Angeles Biomedical Research Institute at UCLA and SIDMAP, LLC, speaking at Advances in Metabolic Profiling 2005
Metabolic Profiles and Biomarkers for Detection and Prediction of Drug Effects Hans Senn of F. Hoffmann-La Roche AG speaking at Advances in Metabolic Profiling 2005.
Predicting the Safety of FDA Regulated Products with Metabolomics Laura Schnackenberg, Center for Metabolomics Research, speaks at Advances in Metabolic Profiling 2005.
The Application of Metabolic Profiling Techniques in Biomarker Discovery in Drug R&D Dr. Ina Schuppe Koistinen, AstraZeneca R&D speaking at Advances in Metabolic Profiling 2005
Metabolomics as a Tool for Biomarker Discovery Dr. Chris Beecher, Vice President of Biochemistry and Technology, Metabolon, Inc., speaking at Advances in Metabolic Profiling 2005